Literature DB >> 16086955

Photodynamic therapy for choroidal neovascularization on late-onset fundus flavimaculatus.

Eric H Souied1, Dominique Pawlak, Michel Algan, David Sayag, Gabriel Coscas, Gisele Soubrane.   

Abstract

PURPOSE: To report the features of three consecutive cases of patients affected with late-onset fundus flavimaculatus (FFM) complicated with choroidal new vessels (CNV) and treated with photodynamic therapy (PDT).
DESIGN: Retrospective interventional case series.
METHODS: Three unrelated women (70- to 74-year-old) presented with unilateral decrease of central vision. Diagnosis of FFM and unilateral CNV was made after fundus examination and fluorescein angiography (FA). PDT was performed on the basis of FA features.
RESULTS: One to three PDTs were needed for the treatment of CNV. At the end of follow-up (15-24 months), no leakage was present and visual acuity was improved in these three cases.
CONCLUSIONS: Occurrence of CNV is a rare event in FFM. In these three eyes, PDT successfully stopped the progression of CNV and blocked leakage. We suggest considering PDT as a treatment for CNV in patients affected with FFM.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16086955     DOI: 10.1016/j.ajo.2005.01.024

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  2 in total

1.  Intravitreal ranibizumab (Lucentis) for choroidal neovascularization associated with Stargardt's disease.

Authors:  Giuseppe Querques; Maria Cecilia Angulo Bocco; Gisele Soubrane; Eric H Souied
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-10-13       Impact factor: 3.117

2.  Intravitreal aflibercept injection and photodynamic treatment of a patient with unilateral subretinal neovascular membrane associated with fundus flavimaculatus.

Authors:  Ali Osman Saatci; Ziya Ayhan; Bora Yüksel; Göktuğ Seymenoğlu; Seenu M Hariprasad
Journal:  Case Rep Ophthalmol Med       Date:  2015-03-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.